June 11, 2020 / 8:32 AM / 25 days ago

BRIEF-Gimv Says FDA Grants Breakthrough Device Designation To GTX Go-2 System

June 11 (Reuters) - GIMV INVESTERINGSMAATSCHAPPIJ VOOR VLANDEREN NV:

* GTX MEDICAL ANNOUNCED THAT US FOOD AND DRUG ADMINISTRATION HAS GRANTED BREAKTHROUGH DEVICE DESIGNATION FOR ITS IMPLANTABLE GO-2 SYSTEM

* THE SYSTEM DESIGNED TO PROMOTE THE RECOVERY OF LEG MOTOR FUNCTIONS AND NEUROLOGICAL CONTROL IN ADULTS WITH SPINAL CORD INJURIES (SCI) AND PARALYSIS

* THE COMPANY ANTICIPATES THE FIRST CLINICAL TRIAL FOR THE COMPLETE GO-2 SYSTEM IN HUMANS TO TAKE PLACE IN 2021 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below